| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-NUFIP2 (456-695) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
NUFIP2 |
| Gene ID: |
57532 |
| Uniprot ID: |
NUFP2_HUMAN |
| Immunogen Region: |
456-695 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 456-695 of human NUFIP2 (NP_065823.1). |
| Immunogen Sequence: |
DMSLTSAAVEQIKTSLFIYP SNMQTMLLSTAQVDLPSQTD QQNLGDIFQNQWGLSFINEP SAGPETVTGKSSEHKVMEVT FQGEYPATLVSQGAEIIPSG TEHPVFPKAYELEKRTSPQV LGSILKSGTTSESGALSLEP SHIGDLQKADTSSQGALVFL SKDYEIESQNPLASPTNTLL GSAKEQRYQRGLERNDSWGS FDLRAAIVYHTKEMESIWNL QKQDPKRIITYNEAMDSPD |
| Function | Binds RNA. |
| Protein Name | Fmr1-Interacting Protein Nufip282 Kda Fmrp-Interacting Protein82-FipCell Proliferation-Inducing Gene 1 ProteinFmrp-Interacting Protein 2Nuclear Fmr1-Interacting Protein 2 |
| Cellular Localisation | NucleusCytoplasmStress GranuleDistribution Is Cell Cycle-ModulatedBeing Cytoplasmic In The G2/M Phase And Accumulating In Nucleus During The G1 Phase |
| Alternative Antibody Names | Anti-Fmr1-Interacting Protein Nufip2 antibodyAnti-82 Kda Fmrp-Interacting Protein antibodyAnti-82-Fip antibodyAnti-Cell Proliferation-Inducing Gene 1 Protein antibodyAnti-Fmrp-Interacting Protein 2 antibodyAnti-Nuclear Fmr1-Interacting Protein 2 antibodyAnti-NUFIP2 antibodyAnti-KIAA1321 antibodyAnti-PIG1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
